China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) Shares Shorted: Short Interest Down 96.1% in October

China SXT Pharmaceuticals, Inc. (NASDAQ:SXTC) was the target of a significant decrease in short interest in the month of October. As of October 30th, there was short interest totaling 28,225 shares, a decrease of 96.1% from the October 15th total of 721,044 shares. Based on an average daily trading volume, of 716,620 shares, the short-interest ratio is currently 0.0 days. Approximately 564.5% of the company’s shares are short sold.

Analysts Set New Price Targets

Several research firms have recently commented on SXTC. Wall Street Zen upgraded China SXT Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Saturday, October 31st. Weiss Ratings cut shares of China SXT Pharmaceuticals from a “sell (e+)” rating to a “sell (e)” rating in a research report on Monday. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the company presently has a consensus rating of “Sell”.

China SXT Pharmaceuticals Trading Down 7.1%

NASDAQ:SXTC opened at $2.88 on Wednesday. The firm’s fifty day simple moving average is $127.92 and its 200 day simple moving average is $12,490.24. China SXT Pharmaceuticals has a twelve month low of $2.71 and a twelve month high of $8,375,880.00. The company has a current ratio of 7.94, a quick ratio of 7.76 and a debt-to-equity ratio of 0.02.

China SXT Pharmaceuticals Company Profile

China SXT Pharmaceuticals, Inc. is a pharmaceutical company focused on the development, manufacture and sale of traditional Chinese medicine (TCM) products. The company produces herbal formulations intended for use in the treatment and management of various health conditions, as well as products positioned for general wellness and health maintenance. Its product portfolio includes prescription medicines, over-the-counter medicines and dietary supplements. The company’s offerings are based on traditional Chinese medicinal practices and may be provided in forms such as herbal extracts, pills and other finished formulations.